Cargando…

M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis

BACKGROUND: The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) encodes for a multifunctional receptor involved in lysosomal enzyme trafficking, fetal organogenesis, cytotoxic T cell-induced apoptosis and tumor suppression. The purpose of this investigation was to determine if...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamieson, Timothy A, Brizel, David M, Killian, J Keith, Oka, Yoshihiko, Jang, Hong-Seok, Fu, Xiaolong, Clough, Robert W, Vollmer, Robin T, Anscher, Mitchell S, Jirtle, Randy L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC151601/ https://www.ncbi.nlm.nih.gov/pubmed/12589712 http://dx.doi.org/10.1186/1471-2407-3-4

Ejemplares similares

IGF2R Genetic Variants, Circulating IGF2 Concentrations and Colon Cancer Risk in African Americans and Whites
por: Hoyo, Cathrine, et al.
Publicado: (2012)

Role of IGF2BPs in head and neck squamous cell carcinoma
por: Wu, Kainan, et al.
Publicado: (2022)

Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTN(IGF1R)
por: Stueven, Noah A., et al.
Publicado: (2023)

Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis
por: Sunpaweravong, Somkiat, et al.
Publicado: (2019)

Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight
por: Hoyo, Cathrine, et al.
Publicado: (2012)

Targeting the TGF-β1 Pathway to Prevent Normal Tissue Injury After Cancer Therapy
por: Anscher, Mitchell S.
Publicado: (2010)

Establishing ADC-Based Histogram and Texture Features for Early Treatment-Induced Changes in Head and Neck Squamous Cell Carcinoma
por: Rodrigues, Anna, et al.
Publicado: (2021)

Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort
por: Soubry, Adelheid, et al.
Publicado: (2013)

Maternal BMI, IGF-I Levels, and Birth Weight in African American and White Infants
por: Vidal, Adriana C., et al.
Publicado: (2013)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients
por: Nejatinamini, Sara, et al.
Publicado: (2018)

Assessment of Heterozygosity and Genome-Wide Analysis of Heterozygosity Regions in Two Duroc Pig Populations
por: Ruan, Donglin, et al.
Publicado: (2022)

Extensive sequence duplication in Arabidopsis revealed by pseudo-heterozygosity
por: Jaegle, Benjamin, et al.
Publicado: (2023)

Chondrosarcoma of the Head and Neck
por: Lee, Sei Young, et al.
Publicado: (2005)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Overexpression of Prothymosin Alpha Predicts Poor Disease Outcome in Head and Neck Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2011)

Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2010)

BCAR3 promotes head and neck cancer growth and is associated with poor prognosis
por: Zhang, Ze, et al.
Publicado: (2021)

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Li, Jing, et al.
Publicado: (2022)

IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer
por: Badarni, Mai, et al.
Publicado: (2021)

Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers
por: Jernvall, P, et al.
Publicado: (1999)

Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL
por: Risinskaya, Natalya, et al.
Publicado: (2022)

Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives
por: Serrano, Nicholas A, et al.
Publicado: (2017)

NBS1 Heterozygosity and Cancer Risk
por: di Masi, Alessandra, et al.
Publicado: (2008)

Loss of Heterozygosity and Its Importance in Evolution
por: Smukowski Heil, Caiti
Publicado: (2023)

Interventions for head and neck cancer survivors: Systematic review
por: Margalit, Danielle N., et al.
Publicado: (2022)

Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma
por: Deng, Xiaoli, et al.
Publicado: (2020)

IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma
por: Hu, Yuan, et al.
Publicado: (2022)

Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas
por: Gasparotto, Daniela, et al.
Publicado: (2011)

Head and Neck Squamous Cell Carcinoma in Western Uganda: Disease of Uncertainty and Poor Prognosis
por: Nabukenya, Jamilah, et al.
Publicado: (2018)

Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Low plasma fibrinogen levels are associated with poor prognosis in cutaneous angiosarcoma of the head and neck
por: Mori, Shoichiro, et al.
Publicado: (2021)

Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma
por: Ahmadi, Mohsen, et al.
Publicado: (2021)

LAT1 is associated with poor prognosis and radioresistance in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2023)

Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders
por: Schaaf, Christian P., et al.
Publicado: (2011)

The Limits of Mean-Field Heterozygosity Estimates under Spatial Extension in Simulated Plant Populations
por: Kitchen, James L., et al.
Publicado: (2012)

Immunohistochemical analysis of undifferentiated and poorly-differentiated head and neck malignancies at a tertiary hospital in Nigeria
por: Adisa, Akinyele O, et al.
Publicado: (2010)

Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance
por: Amini, Arya, et al.
Publicado: (2014)

Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Ram, Ashwin Jaikumar, et al.
Publicado: (2020)

Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer
por: You, Guo-Rung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d52bsce4145rjphjn6nm1f9pir